尾状叶切除对肝门部胆管癌切缘及结局的影响:美国肝外胆道恶性肿瘤联盟多中心分析
本研究基于美国肝外胆道恶性肿瘤联盟数据库,纳入241例接受根治性切除的肝外肝门部胆管癌患者,其中85例行尾状叶切除。结果显示尾状叶切除与更低的最终切缘阳性率相关(P = .01),但Kaplan-Meier分析未显示总生存改善(P = .16),多变量分析中尾状叶切除与总生存或无复发生存无关。
要点
- 尾状叶切除与肝门部胆管癌根治术后更低的切缘阳性率相关(P = .01)。
- 尾状叶切除未显著改善总生存(P = .16),多变量分析亦无生存获益。
- 淋巴结阳性与更差的总生存和无复发生存相关,辅助放化疗与改善生存相关。
核心结论
- 尾状叶切除与肝外肝门部胆管癌患者更大概率获得切缘阴性切除相关。
- 尾状叶切除未显示改善总生存或无复发生存。
- 精确的术前影像评估胆道受累范围对首次手术实现各种程度肝切除至关重要。
研究设计与样本
- 多中心回顾性数据库分析,来自美国肝外胆道恶性肿瘤联盟的1092例胆道恶性肿瘤患者。
- 纳入241例接受根治性意图切除的肝外肝门部胆管癌患者,其中85例行尾状叶切除。
- 比较行与未行尾状叶切除患者的人口学、基线、肿瘤特征及围手术期结局。
主要发现
- 尾状叶切除组最终切缘阳性率更低(P = .01)。
- 尾状叶切除组总生存的Kaplan-Meier曲线未显示优于未切除组(P = .16)。
- 多变量分析中尾状叶切除与总生存或无复发生存改善无关。
- 淋巴结阳性与更差的总生存和无复发生存相关。
- 辅助放化疗与改善的总生存和无复发生存相关。
临床怎么用
- 对肝外肝门部胆管癌行根治性切除时,可考虑联合尾状叶切除以提高切缘阴性率。
- 术前应进行精确影像评估胆道受累范围,以便首次手术时能实施所需程度的肝切除。
- 淋巴结阳性患者预后较差,辅助放化疗可能与改善生存相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to determine the impact of caudate resection on margin status and outcomes during resection of extrahepatic hilar cholangiocarcinoma. METHODS: A database of 1,092 patients treated for biliary malignancies at institutions of the Extrahepatic Biliary Malignancy Consortium was queried for individuals undergoing curative-intent resection for extrahepatic hilar cholangiocarcinoma. Patients who did versus did not undergo concomitant caudate resection were compared with regard to demographic, baseline, and tumor characteristics as well as perioperative outcomes. RESULTS: A total of 241 patients underwent resection for a hilar cholangiocarcinoma, of whom 85 underwent caudate resection. Patients undergoing caudate resection were less likely to have a final positive margin (P = .01). Kaplan-Meier curve of overall survival for patients undergoing caudate resection indicated no improvement over patients not undergoing caudate resection (P = .16). On multivariable analysis, caudate resection was not associated with improved overall survival or recurrence-free survival, although lymph node positivity was associated with worse overall survival and recurrence-free survival, and adjuvant chemoradiotherapy was associated with improved overall survival and recurrence-free survival. CONCLUSION: Caudate resection is associated with a greater likelihood of margin-negative resection in patients with extrahepatic hilar cholangiocarcinoma. Precise preoperative imaging is critical to assess the extent of biliary involvement, so that all degrees of hepatic resections are possible at the time of the initial operation.
引用
- Bhutiani N, Scoggins CR, McMasters KM, et al. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium. Surgery. 2018. PMID: 29306541. doi:10.1016/j.surg.2017.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。